Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says

Go back to Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says
Johnson & Johnson (NYSE: JNJ) Delayed: 259.80 -2.01 (0.77%)
Previous Close $261.81    52 Week High $126.07 
Open $261.23    52 Week Low $94.28 
Day High $264.15    P/E 54.01 
Day Low $258.36    EPS $4.81 
Volume 5,945,395       

Merck & Co. (NYSE: MRK) Delayed: 130.42 -0.5 (0.38%)
Previous Close $130.92    52 Week High $65.46 
Open $129.93    52 Week Low $47.97 
Day High $132.84    P/E 88.72 
Day Low $129.70    EPS $1.47 
Volume 6,343,840       

NOVO-NORDISK A/S (NYSE: NVO) Delayed: 47.17 -0.56 (1.17%)
Previous Close $47.73    52 Week High $59.00 
Open $47.45    52 Week Low $32.80 
Day High $47.67    P/E N/A 
Day Low $46.93    EPS $0.00 
Volume 7,834,033